Links
Organizations
Conferences
Info & Opinion
October 6, 2008
The ClinPage Checklist
22 Questions For Adaptive Trials
As life science organizations consider adaptive clinical trial designs, the process, technology and operational aspects are complex. What to consider.
Ken Getz At DIA
Tufts Data: Veteran P.I.s Drop Out
In the United States, more seasoned veterans in the clinical investigator world drop out. In rest-of-world, it’s the new P.I.’s who are more likely to leave industry-sponsored research.
Finding 36,000 Patients In 6 Months
Parexel’s Post-Approval Boom
Amid high public and Congressional scrutiny, Parexel says special technology, SOPs and hiring techniques help it run large-scale post-approval trials.
Kendle, a global clinical research organization, appointed Thomas B. Smith, MD, as vice president, medical affairs. Dr. Smith will develop and lead the company’s new global medical affairs organization, which will enhance delivery of Phase II-IV services to customers worldwide. This team will serve as medical and therapeutic advisors to… more...
Covance reported strong earnings for the second quarter, with revenue jumping 14 percent to $404 million. The future also looks good. “Continued robust net orders of $481 million helped drive our backlog up 25.9 percent year-on-year to $2.5 billion which positions us for accelerated growth,” said Joe Herring, chairman and… more...
Greg Seminack got a call from a friend who distributed drugs to clinical sites. He was deep in the finance world at the time. Seminack’s buddy mentioned that many of the sites he visited were in dire straits financially. Yes, they had contracted with some of the largest, most profitable… more...
Clinical research company PRA International has agreed to be bought by private equity firm Genstar Capitalfor $790 million. PRA went public in 2004. Genstar currently owns 12.8 percent of PRA shares. Under the agreement, PRA stockholders will be entitled to receive $30.50 in cash for each share of PRA common… more...
Clinical technology suite Phase Forward reported another apparently effortless set of strong financial results. Revenues for the second quarter of 2007 were $31.5 million, a 28 percent increase from $24.7 million in the second quarter of 2006. Within total revenues, electronic data capture license, application hosting and other related revenues… more...
The clinical suite etrials announced the appointment of a new interim chief operations officer and the inauguration of a client services management practice. Peter Benton was named interim COO; he’ll be responsible for managing all clinical operations, support and application development teams. Benton joins etrials with more than 20 years… more...
Sitting there in Arlington, Virginia, at the ExL Pharma meeting on clinical trial design, we had an unexpected humanitarian pang. Was it cruel to put Robert Ruffolo, Wyeth’s president of research and development, on the program? Yes, Ruffolo has been making the rounds of the conference circuit for years. But… more...
